Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersOperating ExpensesOperating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

RxSight (RXST) Operating Expenses (2020 - 2025)

RxSight's Operating Expenses history spans 6 years, with the latest figure at $36.6 million for Q4 2025.

  • For Q4 2025, Operating Expenses fell 2.18% year-over-year to $36.6 million; the TTM value through Dec 2025 reached $151.2 million, up 11.34%, while the annual FY2025 figure was $151.2 million, 11.34% up from the prior year.
  • Operating Expenses reached $36.6 million in Q4 2025 per RXST's latest filing, up from $36.4 million in the prior quarter.
  • In the past five years, Operating Expenses ranged from a high of $39.2 million in Q2 2025 to a low of $12.3 million in Q1 2021.
  • Average Operating Expenses over 5 years is $26.6 million, with a median of $25.9 million recorded in 2023.
  • Peak YoY movement for Operating Expenses: surged 81.08% in 2021, then dropped 2.18% in 2025.
  • A 5-year view of Operating Expenses shows it stood at $17.5 million in 2021, then rose by 27.83% to $22.4 million in 2022, then rose by 27.19% to $28.5 million in 2023, then surged by 31.26% to $37.4 million in 2024, then fell by 2.18% to $36.6 million in 2025.
  • Per Business Quant, the three most recent readings for RXST's Operating Expenses are $36.6 million (Q4 2025), $36.4 million (Q3 2025), and $39.2 million (Q2 2025).